INBP
Integrated Biopharma Inc
$0.16
-0.01 (-5.88%)
At close · Jul 8
Market Cap
$4.97M
Shares
31,059,610
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.16
Open$0.17
Day$0.16–0.17
52W$0.14–0.42
Avg vol 30d4K
Short int2K · 0.0% float · 1.0d
Short vol31%
DataJan 2020–Jul 2026
Filing10-Q · May 8
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−43%
below
Price vs 50-day avg
−20%
below
RSI (14)
32
neutral
MACD trend
Negative
52-week position
7%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−11%
trailing
6-month return
−57%
trailing
YTD return
−56%
this year
Relative strength
−64%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.01% of float · ▼ -14.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
11
low risk · 0–100
Fundamentals
Revenue growth
−7%
Y/Y
Gross margin
13%
expanding
Free cash flow
$1.9M
Balance sheet
$3.6M
net cash
Quant / Vol
risk profile
Volatility
64%
annualized · 1-yr
Max drawdown
−58%
past year
ATR
5.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
filed May 8, 2026
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−43%
Bearish
Price vs 50-day avg
−20%
Bearish
RSI (14)
32
Neutral
MACD trend
Negative
Bearish
52-week position
7%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.01% of float · ▼ -14.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $0
Now $0 · 7%
52-wk high $0
vs 200-day avg -43%
vs 50-day avg -20%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Packaged Foods — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
INBP
this stock
Integrated Biopharma Inc
|
$4.97M | -55.6% | — | — | 0.0% |
|
JBS
Jbs N.V.
|
$38.88B | -18.0% | — | — | 3.5% |
|
KHC
Kraft Heinz Co
|
$29.55B | +4.5% | — | — | 7.6% |
|
GIS
General Mills Inc
|
$19.39B | -20.8% | +4.1% | — | 9.8% |
|
MKC
Mccormick & Co Inc
|
$13.86B | -22.9% | +1.7% | 8.6 | 5.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| INBP | -11.1% | -11.1% | -56.8% | -11.1% | -55.6% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -10.9% | -12.0% | -64.2% | -10.9% | -64.9% |